TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15591746

Group type: EXPERIMENTAL
Intervention: Butyl-2-cyanoacrylate adhesive
Number of subjects: 46

Group type: COMPARATOR
Intervention: Polypropylene mesh with 3/0 Dexon sutures
Number of subjects: 46
Study: 12829670

Group type: EXPERIMENTAL
Intervention: Lower dose radiotherapy (50.4 Gy in 28 fractions)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Higher dose radiotherapy (64.8 Gy in 36 fractions)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Radiotherapy (both doses)
Number of subjects: 203
Study: 9607553

Group type: EXPERIMENTAL
Intervention: Neoadjuvant hormonal treatment (NHT) with leuprolide plus cyproterone acetate
Number of subjects: 0
Study: 8567545

Group type: EXPERIMENTAL
Intervention: Single-breath hyperoxic hypercapnic stimulus (0.01 liter of CO2 in O2)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Single-breath increase of 1 Torr in end-tidal PCO2
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Duration of the closed-loop VI response
Number of subjects: 9
Study: 1369846

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty with 5 different types of prostheses
Number of subjects: 38
Study: 319424

Group type: EXPERIMENTAL
Intervention: Indomethacin + aspirin (150 mg indomethacin daily, 1500 mg aspirin daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Indomethacin (150 mg daily)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 31339011

Group type: EXPERIMENTAL
Intervention: Pioglitazone (15 mg/day)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Glimepiride (2 mg/day)
Number of subjects: 135
Study: 31303277

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham-RMT
Number of subjects: 28
Study: 29258520

Group type: EXPERIMENTAL
Intervention: Physical exercise session (energy expenditure of 250 Kcal, light intensity)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 66
Study: 27777509

Group type: EXPERIMENTAL
Intervention: Cochlear implantation (CI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bone Conduction Devices (BCD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Contralateral Routing of Sound systems (CROS)
Number of subjects: 120
Study: 24142686

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 81

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 81
Study: 22515416

Group type: EXPERIMENTAL
Intervention: valsartan 160 mg
Number of subjects: 293

Group type: COMPARATOR
Intervention: ramipril 5 mg
Number of subjects: 293
Study: 19717887

Group type: EXPERIMENTAL
Intervention: Post-implantation ultrasound (US) imaging
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intra-operative plans on US
Number of subjects: 30

Group type: COMPARATOR
Intervention: CT images performed 4 weeks post-operatively
Number of subjects: 30
Study: 17459221

Group type: COMPARATOR
Intervention: Ulinastatin (300 K units per day) + thymosin alpha1 (Maipuxin, 1.6 mg per day) for 7 days (treatment group 1)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Double dosage of Ulinastatin and thymosin alpha1 (treatment group 2)
Number of subjects: 433
Study: 15141331

Group type: EXPERIMENTAL
Intervention: Oral DFMO at 100 mg/kg body weight every 6 h for 14 days
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oral DFMO at 125 mg/kg body weight every 6 h for 14 days
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oral DFMO at 100 mg/kg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oral DFMO at 125 mg/kg
Number of subjects: 25
Study: 12026026

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation in breastfeeding mothers and infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal vitamin A supplementation during pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improved infant vitamin A status
Number of subjects: 0
Study: 9827708

Group type: EXPERIMENTAL
Intervention: FAM-P regimen (5-FU, doxorubicin, mitomycin C, and OK-432)
Number of subjects: 99

Group type: COMPARATOR
Intervention: FAM regimen (5-FU, doxorubicin, mitomycin C)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: FAM-P regimen
Number of subjects: 99

Group type: COMPARATOR
Intervention: FAM regimen
Number of subjects: 99
Study: 7547226

Group type: EXPERIMENTAL
Intervention: uPA levels and macrophage counts in tumour tissue
Number of subjects: 42
Study: 30417662

Group type: EXPERIMENTAL
Intervention: Combination of rivaroxaban 2.5 mg twice‐daily and aspirin 100 mg daily
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5 mg twice‐daily alone
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin 100 mg daily alone
Number of subjects: 27395
Study: 26718418

Group type: EXPERIMENTAL
Intervention: Mexican diet
Number of subjects: 53

Group type: COMPARATOR
Intervention: US diet
Number of subjects: 53
Study: 25148458

Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (AIs) therapy
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: Functional validation of genes (CTSZ-SLMO2-ATP5E, TRAM2-TMEM14A, MAP4K4)
Number of subjects: 1071

Group type: EXPERIMENTAL
Intervention: SNP genotype-dependent variation in E2 induction
Number of subjects: 1071
Study: 22166167

Group type: EXPERIMENTAL
Intervention: Open-flap surgery (OF)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (BBM)
Number of subjects: 32
Study: 19955739

Group type: EXPERIMENTAL
Intervention: High doses of vitamins (adherence >90% to <99%)
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: High doses of vitamins (adherence >=99%)
Number of subjects: 3357

Group type: COMPARATOR
Intervention: Low adherence (<65%)
Number of subjects: 3357

Group type: EXPERIMENTAL
Intervention: Good adherence (>=80%)
Number of subjects: 3357

Group type: COMPARATOR
Intervention: Poor adherence (<80%)
Number of subjects: 3357
Study: 19033818

Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 10742
Study: 17190130

Group type: EXPERIMENTAL
Intervention: 72 hours PVC
Number of subjects: 221

Group type: COMPARATOR
Intervention: 96 hours PVC
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: 24 hours PVC
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: 48 hours PVC
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Age and intravenous antibiotherapy
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Intravenous steroids
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Internal medicine/infectious diseases department
Number of subjects: 221
Study: 12811568

Group type: EXPERIMENTAL
Intervention: Constant work rate exercise test (0 W followed by 50-W step)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ramp exercise testing (15 W. min(‐1) ramp)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hypothetical DeltaVO2/DeltaWR derived from VO2 step response
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hypothetical and measured DeltaVO2/DeltaWR correlation
Number of subjects: 21
Study: 10781507

Group type: EXPERIMENTAL
Intervention: Hospital eye service follow up
Number of subjects: 403

Group type: COMPARATOR
Intervention: Community optometrists follow up
Number of subjects: 403
Study: 8834905

Group type: EXPERIMENTAL
Intervention: Ceftriaxone diluted in sterile water
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftriaxone diluted in 1% lidocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftriaxone diluted in buffered lidocaine
Number of subjects: 0
Study: 1336526

Group type: EXPERIMENTAL
Intervention: Potassium supplementation (60 mmol/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 3966997

Group type: EXPERIMENTAL
Intervention: Isovolaemic haemodilution
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (panretinal photocoagulation only)
Number of subjects: 38
Study: 30115553

Group type: EXPERIMENTAL
Intervention: SAMe
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 26779855

Group type: EXPERIMENTAL
Intervention: Tapering clopidogrel discontinuation during a two‐week period (n = 25)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Abrupt clopidogrel cessation (n = 24)
Number of subjects: 49
Study: 25561347

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (biopsy procedure twice)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo procedure
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (in subgroup with two or more previous failures)
Number of subjects: 387
Study: 24386434

Group type: EXPERIMENTAL
Intervention: Filtering facepiece respirators with 3 mm H2O pressure drop
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Filtering facepiece respirators with 6 mm H2O pressure drop
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Filtering facepiece respirators with 9 mm H2O pressure drop
Number of subjects: 10
Study: 20061360

Group type: EXPERIMENTAL
Intervention: Intensive glucose control (haemoglobin A(1C) <6.0%)
Number of subjects: 10209

Group type: COMPARATOR
Intervention: Standard glucose control (haemoglobin A(1C) 7.0-7.9%)
Number of subjects: 10209

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 10209

Group type: COMPARATOR
Intervention: Standard arm
Number of subjects: 10209

Group type: EXPERIMENTAL
Intervention: Intensive arm
Number of subjects: 10209
Study: 19031507

Group type: EXPERIMENTAL
Intervention: 24-hour training program on breastfeeding promotion for health providers
Number of subjects: 1491
Study: 15983147

Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg added to lidocaine infiltration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ketorolac 30 mg injected subcutaneously in the contralateral abdominal wall (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 12923398

Group type: EXPERIMENTAL
Intervention: Acetylsalicylate-lysin (500 mg intravenously)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Parecoxib (20 mg intravenously)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nitroprusside (1.6, 3.2, or 4.0 microg/min)
Number of subjects: 40
Study: 10540095

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Granisetron 1 mg plus dexamethasone 5 mg
Number of subjects: 397
Study: 9103076

Group type: EXPERIMENTAL
Intervention: Cell free staphylococcal vaccine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Commercial preparation of staphylococcal antiphagin (Control Group 1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional methods without vaccines (Control Group 2)
Number of subjects: 100
Study: 2070135

Group type: EXPERIMENTAL
Intervention: Red cell transfusions shortly before BMT
Number of subjects: 969

Group type: COMPARATOR
Intervention: No transfusion before BMT
Number of subjects: 969
Study: 6678385

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of clonidine hydrochloride (Group 1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous injection of clonidine hydrochloride (Group 2)
Number of subjects: 24
Study: 30472992

Group type: EXPERIMENTAL
Intervention: Intensive periodontal treatment (IPT) including whole mouth subgingival scaling, surgical periodontal therapy (if good oral hygiene), and supportive periodontal therapy every 3 months.
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control periodontal treatment (CPT) including supra-gingival scaling and polishing at the same timepoints as in the IPT group.
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Intensive periodontal treatment (IPT)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Control periodontal treatment (CPT)
Number of subjects: 264
Study: 26727413

Group type: EXPERIMENTAL
Intervention: Therapist MI‐consistent behaviors (MICO)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Change talk strength (CTS)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Therapist experience in MI
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Client alcohol problem severity
Number of subjects: 174
Study: 24822238

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diclofenac 75 mg
Number of subjects: 40
Study: 22691021

Group type: EXPERIMENTAL
Intervention: Forgiveness treatment (n=41)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Anger-reduction treatment (n=39)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Waitlist control (n=32)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Both treatment conditions
Number of subjects: 112
Study: 19863538

Group type: EXPERIMENTAL
Intervention: Chemotherapy alone
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: MRD detected prior to autologous stem cell transplantation (SCT)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Allogeneic-SCT in first complete remission with MRD positivity pre-transplant
Number of subjects: 161
Study: 18548293

Group type: EXPERIMENTAL
Intervention: Modified condylotomy
Number of subjects: 8

Group type: COMPARATOR
Intervention: Conventional nonsurgical treatment
Number of subjects: 8
Study: 16639486

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Both Etanercept and Infliximab
Number of subjects: 151
Study: 15370078

Group type: EXPERIMENTAL
Intervention: L-Arginine (L-Arg 20 g/500 ml)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 15
Study: 11080405

Group type: COMPARATOR
Intervention: ondansetron 4 mg IV
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: dimenhydrinate 50 mg IV
Number of subjects: 108
Study: 9396185

Group type: EXPERIMENTAL
Intervention: Meta-analysis of treatments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cumulative meta-analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis on individual patient data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Evidence-Based Medicine (EBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochrane Collaboration
Number of subjects: 0
Study: 8294195

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine 1mg and metoclopramide 10mg IV
Number of subjects: 28

Group type: COMPARATOR
Intervention: Meperidine 75mg and hydroxyzine 75mg IM
Number of subjects: 28
Study: 3319459

Group type: EXPERIMENTAL
Intervention: 5-ASA enemas
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 29436486

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 26875922

Group type: EXPERIMENTAL
Intervention: Jaw thrust (Group J)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trapezius squeezing test (Group T)
Number of subjects: 100
Study: 24704801

Group type: EXPERIMENTAL
Intervention: Pre‐emptive methylprednisolone infusion (5 mg/kg) before radiotherapy (Group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Short‐course radiotherapy without methylprednisolone infusion (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Pre‐emptive methylprednisolone infusion (Group 1)
Number of subjects: 120
Study: 22344753

Group type: EXPERIMENTAL
Intervention: Multidisciplinary specialist mental health consultation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 44
Study: 20479348

Group type: EXPERIMENTAL
Intervention: Collagen sponge group
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 115
Study: 18589271

Group type: EXPERIMENTAL
Intervention: Bioabsorbable interference screws
Number of subjects: 100

Group type: COMPARATOR
Intervention: Titanium interference screws
Number of subjects: 100
Study: 15869338

Group type: EXPERIMENTAL
Intervention: Empirically supported treatments (ESTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized trial methodology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correlational research designs proposed by Westen et al.
Number of subjects: 0
Study: 12592686

Group type: EXPERIMENTAL
Intervention: Astragalus injection (20 ml in 250 ml of normal saline, once per day for 21 days, 4 courses)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Chemotherapy (control group)
Number of subjects: 120
Study: 10342509

Group type: EXPERIMENTAL
Intervention: Terlipressin-glycerin trinitrate combination (TER-GTN)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 8564726

Group type: EXPERIMENTAL
Intervention: Terfenadine (120 mg/die for 7 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1720262

Group type: EXPERIMENTAL
Intervention: High dose aprotinin (2 million KIU after induction of anesthesia followed by 500,000 KIU/h infusion throughout the operation)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High dose aprotinin
Number of subjects: 50
Study: 7045313

Group type: EXPERIMENTAL
Intervention: Vidarabine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 31578631

Group type: EXPERIMENTAL
Intervention: Photoselective laser vaporisation of the prostate (PVP)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Risk factors for postoperative UTIs
Number of subjects: 665

Group type: COMPARATOR
Intervention: Antimicrobial prophylaxis
Number of subjects: 665
Study: 31852355

Group type: EXPERIMENTAL
Intervention: 6-grass-pollen-allergoid (Allergovit®) treatment initiated during pollen season (Group-A)
Number of subjects: 240

Group type: COMPARATOR
Intervention: 6-grass-pollen-allergoid (Allergovit®) treatment initiated outside pollen season (Group-B)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 240
Study: 28392271

Group type: EXPERIMENTAL
Intervention: Progressive high intensity power training, 2 sessions per week for 12 weeks
Number of subjects: 47

Group type: COMPARATOR
Intervention: No interventions (control group)
Number of subjects: 47
Study: 25495666

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy tablet (SLIT-tablet) MK-7243 (2800 BAU/75 000 SQ-T)
Number of subjects: 4195

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4195
Study: 24911342

Group type: EXPERIMENTAL
Intervention: Methylene blue injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard manual palpation technique
Number of subjects: 100
Study: 22342469

Group type: EXPERIMENTAL
Intervention: Vaginal danazol 400mg
Number of subjects: 91

Group type: COMPARATOR
Intervention: Oral danazol 600mg
Number of subjects: 91
Study: 20885182

Group type: EXPERIMENTAL
Intervention: Health information exchange between medical and ancillary care providers for 2 years using electronic health records and printouts.
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group (no health information exchange).
Number of subjects: 254
Study: 17074328

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 16222884

Group type: EXPERIMENTAL
Intervention: FGF 1 l/min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: FGF 2 l/min
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: FGF 4 l/min
Number of subjects: 90
Study: 12148830

Group type: EXPERIMENTAL
Intervention: Semi-automatic method to measure and quantify geometrical and topological properties of continuous vascular trees from fundus images.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Semi-automatic method applied to normotensive subjects.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Semi-automatic method applied to hypertensive subjects.
Number of subjects: 20
Study: 10431937

Group type: EXPERIMENTAL
Intervention: Self-monitoring intervention with additional phone calls and daily mailings during the holiday season
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard weekly cognitive-behavioral treatment for obesity (comparison group)
Number of subjects: 57
Study: 7589022

Group type: EXPERIMENTAL
Intervention: Dipyrone 2 g i.m.
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Dipyrone 2 g i.v.
Number of subjects: 293

Group type: COMPARATOR
Intervention: Dipyrone 1 g i.m.
Number of subjects: 293

Group type: COMPARATOR
Intervention: Dipyrone 1 g i.v.
Number of subjects: 293

Group type: COMPARATOR
Intervention: Diclofenac sodium 75 mg i.m.
Number of subjects: 293

Group type: COMPARATOR
Intervention: Diclofenac sodium 75 mg i.v.
Number of subjects: 293
Study: 2405777

Group type: EXPERIMENTAL
Intervention: Radiation.MCNU (MR group) with 50-60 Gy irradiation and 2 mg/kg MCNU intravenously on the initial day and 6 weeks later.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Radiation.MCNU.interferon-beta (IMR group) with 50-60 Gy irradiation and 2 x 10(6) IU/m2 interferon-beta intravenously for 5 serial days every eight weeks.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Combined therapy of MCNU and interferon-beta.
Number of subjects: 19
Study: 6344295

Group type: EXPERIMENTAL
Intervention: Intravenous prostaglandin E1 (PGE1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31492661

Group type: EXPERIMENTAL
Intervention: Increased abdominal subcutaneous adipose tissue (ScAT) inflammatory gene expression
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Increased systemic low-grade inflammation profile
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Distinct abdominal ScAT transcriptome profiles
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Upregulated genes related to extracellular remodeling
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Upregulated genes related to inflammation
Number of subjects: 368
Study: 27723281

Group type: EXPERIMENTAL
Intervention: Tabalumab (BAFF-blocking IgG4 monoclonal antibody)
Number of subjects: 1760

Group type: COMPARATOR
Intervention: Control (healthy donors)
Number of subjects: 1760
Study: 26718394

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) designed to reduce drinking to cope (DTC) and anxiety symptoms
Number of subjects: 218

Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation Training (PMRT) designed to reduce anxiety symptoms only
Number of subjects: 218
Study: 25061952

Group type: EXPERIMENTAL
Intervention: 1 long clinical day (12 hours)
Number of subjects: 146

Group type: COMPARATOR
Intervention: 2 shorter clinical days (7-8 hours each)
Number of subjects: 146
Study: 21688163

Group type: EXPERIMENTAL
Intervention: Medical Qigong (MQ) program for 10 weeks
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual health care (Control)
Number of subjects: 81